SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-17
👔
PUMA BIOTECHNOLOGY, INC.
@PBYI_InsiderForm 4 Filing: WILSON TROY EDWARD Sells $46K of $PBYI
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
PUMA BIOTECHNOLOGY, INC.
Ticker: $PBYI
Transaction Value
$46K
Price/Share: $9.10
transaction date
2026-09-14
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, WILSON TROY EDWARD, holds the title of Director at PUMA BIOTECHNOLOGY, INC..
On 2026-09-14, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $9.10 per share, resulting in a total market-relevant value of $46K.
Executive Summary Summary
WILSON TROY EDWARD (Director) sold $46K of $PBYI
Post-Transaction Position: 54,750 shares
SEC Accession No: 0001437749-26-030597 (CIK: 1589597)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.